Mariann Gjervik Heldahl

  • Audiophysicist; PhD
  • +47 23 07 16 98

Publications 2023

Myhrum M, Heldahl MG, Rødvik AK, Tvete OE, Jablonski GE (2023)
Validation of the Norwegian Version of the Speech, Spatial and Qualities of Hearing Scale (SSQ)
Audiol Neurootol, 29 (2), 124-135
DOI 10.1159/000534197, PubMed 37918367

Publications 2022

Greisiger R, Heldahl MG, Myhrum M, Sørensen TM, Dammerud JJ, Rasmussen K, Korslund H, Bunne M, Jablonski GE (2022)
Effect of Proximity to the Modiolus for the Cochlear CI532 Slim Modiolar Electrode Array on Evoked Compound Action Potentials and Programming Levels
Audiol Neurootol, 27 (5), 397-405
DOI 10.1159/000524256, PubMed 35504247

Publications 2019

Heldahl MG, Eksveen B, Bunne M (2019)
Cochlear implants in eight children with Down Syndrome - Auditory performance and challenges in assessment
Int J Pediatr Otorhinolaryngol, 126, 109636
DOI 10.1016/j.ijporl.2019.109636, PubMed 31442869

Publications 2017

Myhrum M, Strøm-Roum H, Heldahl MG, Rødvik AK, Eksveen B, Landsvik B, Rasmussen K, Tvete OE (2017)
Sequential Bilateral Cochlear Implantation in Children: Outcome of the Second Implant and Long-Term Use
Ear Hear, 38 (3), 301-313
DOI 10.1097/AUD.0000000000000383, PubMed 27828788

Publications 2016

Myhrum M, Tvete OE, Heldahl MG, Moen I, Soli SD (2016)
The Norwegian Hearing in Noise Test for Children
Ear Hear, 37 (1), 80-92
DOI 10.1097/AUD.0000000000000224, PubMed 26462169

Publications 2014

Teruel JR, Heldahl MG, Goa PE, Pickles M, Lundgren S, Bathen TF, Gibbs P (2014)
Dynamic contrast-enhanced MRI texture analysis for pretreatment prediction of clinical and pathological response to neoadjuvant chemotherapy in patients with locally advanced breast cancer
NMR Biomed, 27 (8), 887-96
DOI 10.1002/nbm.3132, PubMed 24840393

Publications 2011

Bathen TF, Heldahl MG, Sitter B, Vettukattil R, Bofin A, Lundgren S, Gribbestad IS (2011)
In vivo MRS of locally advanced breast cancer: characteristics related to negative or positive choline detection and early monitoring of treatment response
MAGMA, 24 (6), 347-57
DOI 10.1007/s10334-011-0280-9, PubMed 21909791

Heldahl MG, Lundgren S, Jensen LR, Gribbestad IS, Bathen TF (2011)
Monitoring neoadjuvant chemotherapy in breast cancer patients: improved MR assessment at 3 T?
J Magn Reson Imaging, 34 (3), 547-56
DOI 10.1002/jmri.22642, PubMed 21761463

Jensen LR, Garzon B, Heldahl MG, Bathen TF, Lundgren S, Gribbestad IS (2011)
Diffusion-weighted and dynamic contrast-enhanced MRI in evaluation of early treatment effects during neoadjuvant chemotherapy in breast cancer patients
J Magn Reson Imaging, 34 (5), 1099-109
DOI 10.1002/jmri.22726, PubMed 22002757

Publications 2010

Heldahl MG, Bathen TF, Rydland J, Kvistad KA, Lundgren S, Gribbestad IS, Goa PE (2010)
Prognostic value of pretreatment dynamic contrast-enhanced MR imaging in breast cancer patients receiving neoadjuvant chemotherapy: overall survival predicted from combined time course and volume analysis
Acta Radiol, 51 (6), 604-12
DOI 10.3109/02841851003782059, PubMed 20429756

Page visits: 5522